Citation Impact
Citing Papers
Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: Assessment of an oral agent that stimulates erythropoietin production
2005 StandoutNobel
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Sialic Acid Associated with αvβ3 Integrin Mediates HIV-1 Tat Protein Interaction and Endothelial Cell Proangiogenic Activation
2012
Neutrophil MMP-9 Proenzyme, Unencumbered by TIMP-1, Undergoes Efficient Activation in Vivo and Catalytically Induces Angiogenesis via a Basic Fibroblast Growth Factor (FGF-2)/FGFR-2 Pathway
2009
Hallmarks of Cancer: The Next Generation
2011 Standout
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
HLF/HIF-2α is a key factor in retinopathy of prematurity in association with erythropoietin
2003
Shedding of Membrane Vesicles Mediates Fibroblast Growth Factor-2 Release from Cells
2003
Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles
2001
Suppression of Retinal Neovascularization by Erythropoietin siRNA in a Mouse Model of Proliferative Retinopathy
2009
Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1
2000 StandoutNobel
Diabetic retinopathy
2010 Standout
pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
2007 StandoutNobel
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
2008 StandoutNobel
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Hydrophobic mismatch drives self-organization of designer proteins into synthetic membranes
2024 StandoutNobel
The role of radical reactions in organomercurials impact on lipid peroxidation
2006
Imaging the Glycosylation State of Cell Surface Glycoproteins by Two‐Photon Fluorescence Lifetime Imaging Microscopy
2013 StandoutNobel
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1
2001
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Cell-penetrating Peptides
2002
Role of the N-terminal Catalytic Domain of Angiotensin-converting Enzyme Investigated by Targeted Inactivation in Mice
2004 StandoutNobel
Age-dependent Defect in Vascular Endothelial Growth Factor Expression Is Associated with Reduced Hypoxia-inducible Factor 1 Activity
2000 StandoutNobel
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
2002 StandoutNobel
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Diabetic Retinopathy
2012 Standout
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo
2006 StandoutNobel
Erythropoietin as a Retinal Angiogenic Factor in Proliferative Diabetic Retinopathy
2005
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
The role of erythropoietin in regulating angiogenesis
2004
Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx
2001
Complexes of Plasmid DNA with Basic Domain 47-57 of the HIV-1 Tat Protein Are Transferred to Mammalian Cells by Endocytosis-mediated Pathways
2003
Hypoxia-inducible Factor-1 Deficiency Results in Dysregulated Erythropoiesis Signaling and Iron Homeostasis in Mouse Development
2006 StandoutNobel
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer
2004
The Mouse C2C12 Myoblast Cell Surface N-Linked Glycoproteome
2009
Anemia of Chronic Disease
2005 Standout
Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells
2005
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Sialidase Specificity Determined by Chemoselective Modification of Complex Sialylated Glycans
2012
Serpin Structure, Mechanism, and Function
2002 Standout
Identification and transcriptome analysis of erythroblastic island macrophages
2019 StandoutNobel
Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
2002 StandoutNobel
Erythropoietin-Induced Activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK Pathways Promotes Malignant Cell Behavior in a Modified Breast Cancer Cell Line
2010
Expression of Concern: Bcl‐2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF‐1mediated transcriptional activity
2002
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Nonviral Vectors for Gene Delivery
2008 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Metabolic reprogramming by HIF-1 promotes the survival of bone marrow–derived angiogenic cells in ischemic tissue
2011 StandoutNobel
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
2001
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
2004 StandoutNobel
Tools and Tactics for the Optical Detection of Mercuric Ion
2008 Standout
Reactivation of Hepatic EPO Synthesis in Mice After PHD Loss
2010 StandoutScienceNobel
Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion Injury
2003 StandoutNobel
Matrix Proteases in Health and Disease
2012
Erythropoietin both protects from and reverses experimental diabetic neuropathy
2004
Vascular tumors in livers with targeted inactivation of the von Hippel–Lindau tumor suppressor
2001
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Protein Sorting at thetrans-Golgi Network
2014 Nobel
Phosphatidylinositol-3-Kinase Signaling Is Required for Erythropoietin-Mediated Acute Protection Against Myocardial Ischemia/Reperfusion Injury
2004 StandoutNobel
Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization
2003
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin
2011 StandoutNobel
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Angiogenesis in Endocrine Tumors
2003
Erythropoietin receptor signalling is required for normal brain development
2002
The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo
2003
Coexistence of Quiescent and Active Adult Stem Cells in Mammals
2010 StandoutScience
Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle
2015 StandoutNobel
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Treatment of erythropoietin deficiency in mice with systemically administered siRNA
2012 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
Works of Roberta Giuliani being referenced
Phenotypic behavior of C2C12 myoblasts upon expression of the dystrophy‐related caveolin‐3 P104L and TFT mutants
2007
Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells
2003
The Basic Domain in HIV-1 Tat Protein as a Target for Polysulfonated Heparin-mimicking Extracellular Tat Antagonists
1998
Antioxidant potential and gap junction-mediated intercellular communication as early biological markers of mercuric chloride toxicity in the MDCK cell line
2002
Role of endothelial cell extracellular signal-regulated kinase1/2 in urokinase-type plasminogen activator upregulation and in vitro angiogenesis by fibroblast growth factor-2
1999
Human Erythropoietin Induces a Pro-Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo
1999
In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2
1999
Analysis of three μ1‐AP1 subunits during zebrafish development
2013
Thrombospondin‐1/HIV‐1 Tat protein interaction: modulation of the biological activity of extracellular Tat
2000